收藏切换
Effect of imatinib adjuvant chemotherapy on breast cancer and its influence on FOXA1, GP73 and tumor markers
收藏切换
Han SUN1, Lihong ZHOU2, Yifei TANG1, *
World Clinical Drug | 2025, 46(4) : 362 - 366
Less
收藏切换
World Clinical Drug | 2025, 46(4): 362-366
• Article •
Effect of imatinib adjuvant chemotherapy on breast cancer and its influence on FOXA1, GP73 and tumor markers
Full
Han SUN1, Lihong ZHOU2, Yifei TANG1, *
Affiliations
  • 1.Department of Pharmacy, Shanghai Anting Hospital, Shanghai 201805, China
  • 2.Department of Oncology, Shanghai Hospital of Traditional Chinese Medicine, Shanghai 200071, China
Published: 2025-04-10 doi: 10.13683/j.wph.2025.04.007
Outline
收藏切换
Objective

To investigate the efficacy of imatinib in the treatment of breast cancer and forkhead box protein (FOX)A1, Golgi apparatus protei (GP)73 and tumor markers.

Methods

A total of 100 breast cancer patients treated in Shanghai hospital of traditional Chinese medicine from March 2021 to February 2023 were selected and divided into observation group and control group by simple randomization method, with 50 cases in each group. The control group was treated with paclitaxel combined with carboplatin, and the observation group was treated with imatinib based on the control group. Clinical efficacy, FOXA1, GP73, carcinoembryonic antigen (CEA), carbohydrate antigen (CA)125, CA153, estrogens and the incidence of adverse reactions were compared between the two groups.

Results

After treatment, the total effective rate of observation group was higher than that of control group (90.00% vs. 70.00%, P<0.05). The FOXA1 level in both groups was higher than before treatment, and the observation group was higher than the control group (P<0.05). The levels of GP73, CEA, CA125, CA153, estrone, estradiol and estrogen receptors in both groups were lower than before treatment, and the observation group was lower than the control group (P<0.05). There were no significant differences in the incidence of adverse reactions and complications between the two groups (P>0.05).

Conclusion

Adjuvant chemotherapy of imatinib can improve the levels of FOXA1, GP73 and tumor markers in breast cancer patients, and effectively control the disease.

imatinib  /  breast cancer  /  fractionin  /  golgi protein  /  tumor marker
孙晗, 周利红, 汤逸斐. 伊马替尼辅助化疗乳腺癌效果及对FOXA1、GP73及肿瘤标志物的影响分析. 世界临床药物, 2025 , 46 (4) : 362 -366 . DOI: 10.13683/j.wph.2025.04.007
Han SUN, Lihong ZHOU, Yifei TANG. Effect of imatinib adjuvant chemotherapy on breast cancer and its influence on FOXA1, GP73 and tumor markers[J]. World Clinical Drug, 2025 , 46 (4) : 362 -366 . DOI: 10.13683/j.wph.2025.04.007
Year 2025 volume 46 Issue 4
66
11
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.04.007
  • Receive Date:2024-10-12
  • Online Date:2026-11-09
  • Published:2025-04-10
Article Data
Affiliations
History
  • Received:2024-10-12
  • Revised:2025-01-26
Affiliations
    1.Department of Pharmacy, Shanghai Anting Hospital, Shanghai 201805, China
    2.Department of Oncology, Shanghai Hospital of Traditional Chinese Medicine, Shanghai 200071, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.04.007
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT